Three synchronous malignancies in a patient with DICER1 syndrome (English)
- New search for: Moke, Diana J.
- New search for: Thomas, Stefanie M.
- New search for: Hiemenz, Matthew C.
- New search for: Nael, Ali
- New search for: Wang, Kasper
- New search for: Shillingford, Nick
- New search for: Biegel, Jaclyn A.
- New search for: Mascarenhas, Leo
- New search for: Moke, Diana J.
- New search for: Thomas, Stefanie M.
- New search for: Hiemenz, Matthew C.
- New search for: Nael, Ali
- New search for: Wang, Kasper
- New search for: Shillingford, Nick
- New search for: Biegel, Jaclyn A.
- New search for: Mascarenhas, Leo
In:
European journal of cancer
;
93
;
140-143
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:Three synchronous malignancies in a patient with DICER1 syndrome
-
Contributors:Moke, Diana J. ( author ) / Thomas, Stefanie M. ( author ) / Hiemenz, Matthew C. ( author ) / Nael, Ali ( author ) / Wang, Kasper ( author ) / Shillingford, Nick ( author ) / Biegel, Jaclyn A. ( author ) / Mascarenhas, Leo ( author )
-
Published in:European journal of cancer ; 93 ; 140-143
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2018-01-01
-
Size:4 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 93
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Integrative expression quantitative trait locus–based analysis of colorectal cancer identified a functional polymorphism regulating SLC22A5 expressionZou, Danyi / Lou, Jiao / Ke, Juntao / Mei, Shufang / Li, Jiaoyuan / Gong, Yajie / Yang, Yang / Zhu, Ying / Tian, Jianbo / Chang, Jiang et al. | 2018
- 10
-
Hallmarks of cancer: The CRISPR generationMoses, Colette / Garcia-Bloj, Benjamin / Harvey, Alan R. / Blancafort, Pilar et al. | 2018
- 19
-
A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival resultsPivot, X. / Bondarenko, I. / Nowecki, Z. / Dvorkin, M. / Trishkina, E. / Ahn, J.-H. / Im, S.-A. / Sarosiek, T. / Chatterjee, S. / Wojtukiewicz, M.Z. et al. | 2018
- 28
-
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialPasquali, Sandro / Colombo, Chiara / Pizzamiglio, Sara / Verderio, Paolo / Callegaro, Dario / Stacchiotti, Silvia / Martin Broto, Javier / Lopez-Pousa, Antonio / Ferrari, Stefano / Poveda, Andres et al. | 2018
- 37
-
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group surveyLevy, Antonin / Faivre-Finn, Corinne / Hasan, Baktiar / De Maio, Eleonora / Berghoff, Anna S. / Girard, Nicolas / Greillier, Laurent / Lantuéjoul, Sylvie / O'Brien, Mary / Reck, Martin et al. | 2018
- 47
-
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task forceScarisbrick, Julia J. / Hodak, Emmilia / Bagot, Martine / Stranzenbach, Rene / Stadler, Rudolf / Ortiz-Romero, Pablo L. / Papadavid, Evangelia / Evison, Felicity / Knobler, Robert / Quaglino, Pietro et al. | 2018
- 57
-
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphomaEl-Galaly, Tarec Christoffer / Cheah, Chan Yoon / Bendtsen, Mette Dahl / Nowakowski, Grzegorz S. / Kansara, Roopesh / Savage, Kerry J. / Connors, Joseph M. / Sehn, Laurie H. / Goldschmidt, Neta / Shaulov, Adir et al. | 2018
- 69
-
Clonal evolution and heterogeneity in metastatic head and neck cancer—An analysis of the Austrian Study Group of Medical Tumour Therapy study groupMelchardt, Thomas / Magnes, Teresa / Hufnagl, Clemens / Thorner, Aaron R. / Ducar, Matthew / Neureiter, Daniel / Tränkenschuh, Wolfgang / Klieser, Eckhard / Gaggl, Alexander / Rösch, Sebastian et al. | 2018
- 79
-
Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)Hagiwara, Yasuhiro / Ohashi, Yasuo / Uesaka, Katsuhiko / Boku, Narikazu / Fukutomi, Akira / Okamura, Yukiyasu / Konishi, Masaru / Matsumoto, Ippei / Kaneoka, Yuji / Shimizu, Yasuhiro et al. | 2018
- 89
-
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluationMeregaglia, Michela / Cairns, John / Licitra, Lisa / Bossi, Paolo et al. | 2018
- 99
-
Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancerWu, Shi-Xiu / Wang, LV-Hua / Luo, Hong-Lei / Xie, Cong-Ying / Zhang, Xue-Bang / Hu, Wei / Zheng, An-Ping / Li, Duo-Jie / Zhang, Hong-Yan / Xie, Cong-Hua et al. | 2018
- 108
-
Costs of screening for prostate cancer: Evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register dataBooth, Neill / Rissanen, Pekka / Tammela, Teuvo L.J. / Taari, Kimmo / Talala, Kirsi / Auvinen, Anssi et al. | 2018
- 119
-
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)Stahl, Michael / Maderer, Annett / Lordick, Florian / Mihaljevic, Andre L. / Kanzler, Stefan / Hoehler, Thomas / Thuss-Patience, Peter / Mönig, Stefan / Kunzmann, Volker / Schroll, Sebastian et al. | 2018
- 127
-
Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?Minicozzi, Pamela / Walsh, Paul M. / Sánchez, Maria-José / Trama, Annalisa / Innos, Kaire / Marcos-Gragera, Rafael / Dimitrova, Nadya / Botta, Laura / Johannesen, Tom B. / Rossi, Silvia et al. | 2018
- 138
-
European Academy of Cancer Sciences—Designation of Comprehensive Cancer Centres of ExcellenceRingborg, Ulrik / Celis, Julio / Eggermont, Alexander / Berns, Anton et al. | 2018
- 140
-
Three synchronous malignancies in a patient with DICER1 syndromeMoke, Diana J. / Thomas, Stefanie M. / Hiemenz, Matthew C. / Nael, Ali / Wang, Kasper / Shillingford, Nick / Biegel, Jaclyn A. / Mascarenhas, Leo et al. | 2018
- 144
-
Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1/anti-PDL1 checkpoint inhibitors?Pradère, P. / Boutros, C. / Scoazec, J.Y. / Dorfmüller, P. / Leroy-Ladurie, F. / Boulate, D. / Le Pavec, J. / Robert, C. et al. | 2018
- 147
-
Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanomaTétu, Pauline / Mangana, Joanna / Dummer, Reinhard / Dutriaux, Caroline / Beneton, Nathalie / Dalle, Stéphane / Meyer, Nicolas / Oriano, Bastien / Michielin, Olivier / Lebbe, Céleste et al. | 2018
- 150
-
Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumabSatzger, Imke / Ivanyi, Philipp / Länger, Florian / Kreipe, Hans-Heinrich / Schaper-Gerhardt, Katrin / Beutel, Gernot / Cornberg, Markus / Gutzmer, Ralf et al. | 2018
- 154
-
Letter to the Editor regarding the paper by N. Azzam et al. 'Germline polymorphisms on RET proto-oncogene involved in medullary thyroid carcinoma in a Druze family'Mathiesen, Jes Sloth / Godballe, Christian / Brusgaard, Klaus et al. | 2018
- 156
-
Corrigendum to "Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial" [Eur J Cancer 87 (2017) 122–130]Verlingue, Loic / Malka, David / Allorant, Adrien / Massard, Christophe / Ferté, Charles / Lacroix, Ludovic / Rouleau, Etienne / Auger, Nathalie / Ngo, Maud / Nicotra, Claudio et al. | 2018
- 158
-
Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116–124]Valpione, Sara / Carlino, Matteo S. / Mangana, Johanna / Mooradian, Meghan J. / McArthur, Grant / Schadendorf, Dirk / Hauschild, Axel / Menzies, Alexander M. / Arance, Ana / Ascierto, Paolo A. et al. | 2018